EcoDrugPlus

V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog

Ensembl ID : ENSOSIG00000015310
Gene Symbol: KRAS
1 Cross references
207 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 2

Ensembl ID : ENSOSIG00000015070
Gene Symbol: AKT2
1 Cross references
210 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 2, Like

Ensembl ID : ENSOSIG00000015063
Gene Symbol: AKT2L
1 Cross references
161 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 3a

Ensembl ID : ENSOSIG00000005595
Gene Symbol: AKT3A
1 Cross references
203 Possible Orthologues:

V-Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A

Ensembl ID : ENSOSIG00000001123
Gene Symbol: RELA
1 Cross references
199 Possible Orthologues:

Vascular Endothelial Growth Factor Ab

Ensembl ID : ENSOSIG00000015733
Gene Symbol: VEGFAB
1 Cross references
201 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSOSIG00000019223
Gene Symbol: VDR
1 Cross references
388 Possible Orthologues:

Vitamin K Epoxide Reductase Complex, Subunit 1

Ensembl ID : ENSOSIG00000007847
Gene Symbol: VKORC1
1 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSOSIG00000022262
Gene Symbol: XDH
1 Cross references
208 Possible Orthologues:

Zgc:171772

Ensembl ID : ENSOSIG00000008063
Gene Symbol: ZGC:171772
1 Cross references
420 Possible Orthologues:

Ensembl ID : ENSOSIG00000008764
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSOSIG00000022515
Gene Symbol: -
Cross references: -
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).